![Martin Treder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Treder
Fondatore presso
LTZ Therapeutics, Inc.
Profilo
Martin Treder was the founder of U3 Pharma AG, founded in 2001, serving as Research Director in 2002.
Dr. Treder was the founder of CT Atlantic Ltd., founded in 2008, serving as Chief Scientific Officer from 2008 to 2014.
Dr. Treder is the founder of LTZ Therapeutics, Inc., founded in 2021, serving as Chief Scientific Officer since 2021.
Dr. Treder is the founder of Shenzhen LTZ Therapeutics Co., Ltd., founded in 2022.
Dr. Treder was Chief Scientific Officer at Affimed NV from 2015 to 2019.
Dr. Treder completed undergraduate studies at Monash University and earned a doctorate from Technische Universität München.
Posizioni attive di Martin Treder
| Società | Posizione | Inizio |
|---|---|---|
LTZ Therapeutics, Inc.
 LTZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as immunotherapy-focused biotech company which develops novel therapies | Fondatore | 01/01/2021 |
Precedenti posizioni note di Martin Treder
| Società | Posizione | Fine |
|---|---|---|
| AFFIMED N.V. | Direttore Tecnico/Scientifico/R&S | 22/05/2019 |
CT Atlantic Ltd.
 CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development of human-derived antibodies for the treatment of cancer | Fondatore | 01/12/2014 |
U3 Pharma AG
 U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment | Fondatore | 01/10/2008 |
Shenzhen LTZ Therapeutics Co., Ltd.
 Shenzhen LTZ Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy drugs for cancer and complex diseases | Fondatore | - |
Formazione di Martin Treder
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Affimed NV
 Affimed NV Pharmaceuticals: MajorHealth Technology Discovers and develops antibody-based therapeutic drugs | Health Technology |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
U3 Pharma AG
U3 Pharma AG Miscellaneous Commercial ServicesCommercial Services Researches and develops novel targeted therapeutics used for cancer treatment | Commercial Services |
CT Atlantic Ltd.
CT Atlantic Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development of human-derived antibodies for the treatment of cancer | Commercial Services |
LTZ Therapeutics, Inc.
LTZ Therapeutics, Inc. BiotechnologyHealth Technology Operates as immunotherapy-focused biotech company which develops novel therapies | Health Technology |
Shenzhen LTZ Therapeutics Co., Ltd.
Shenzhen LTZ Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapy drugs for cancer and complex diseases | Health Technology |
